Joost Breeksema - The Interdisciplinary Conference on Psychedelic Research
Release Date: 02/04/2020
Psychedelics Today
Logan Davidson joins the show to talk about the fast-moving world of Ibogaine in American and why state-based leadership is shaping the future of psychedelic reform. Davidson is the executive director of , the legislative director at , and a key strategist behind Texas’ landmark interest in ibogaine research. He also advises for . His work sits at the intersection of science, policy, and lived experience, and this conversation offers a clear look into what is happening right now. Early Themes: The Rise of State Advocacy Davidson explains how he entered politics at nineteen and how his...
info_outlinePsychedelics Today
In this episode, joins Kyle Buller to explore truth, healing, and psychedelic-assisted psychotherapy through the lens of his new book, . A clinical psychologist, ordained Zen Buddhist monk, retreat leader, and fellow at the Institute of Noetic Sciences, he blends Buddhist psychology, trauma work, and consciousness studies. The discussion focuses on how people discover and live their truth, and why that truth becomes the core medicine in healing. Early in the Podcast with Michael Sapiro describes how years of clinical work and retreat facilitation shaped his understanding of healing....
info_outlinePsychedelics Today
sits at the center of this wide ranging conversation between Psychedelics Today co-founders Joe Moore and Kyle Buller. Drawing from decades of personal practice and assorted types of breathwork facilitation, they explore how breathwork methods from the Grof lineage including can prepare people for psychedelic work, support difficult journeys, and deepen integration over time. Kyle shares how his near death experience, somatic training, and breathwork facilitation shaped this new course on breathwork foundations, while Joe reflects on how reading Dr Stanislav Grof and years of experience in...
info_outlinePsychedelics Today
Alexander joins Psychedelics Today to explore how psychedelics, culture, and power shape each other. A writer, facilitator, and co founder of the conference and the media platform , he has spent years thinking about how psychedelic experiences ripple into politics, economics, conflict, and community. In this episode, he and Joe trace the path from early internet forums to today’s psychedelic renaissance, and ask what it would mean to bring a truly psychedelic perspective into our institutions. Beiner is less interested in psychedelics as a niche medical tool and more interested in how they...
info_outlinePsychedelics Today
Overview Evelyn Eddy Shoop PMHNP-BC joins Psychedelics Today to share her journey from Division I athlete to psychiatric mental health nurse practitioner and psilocybin research participant. In this conversation, she explains how sports injuries, OCD, and intensive treatment led her into psychiatry and eventually into a psilocybin clinical trial at Yale. Her story weaves together lived experience, clinical training, and a call for more humane systems of care and better qualitative data in psychedelic science. Early Themes: Injury, OCD, and Choosing Psychiatry Early in the episode, Evelyn...
info_outlinePsychedelics Today
In this episode, Joe Moore sits down with Dr. Jason Konner, a longtime oncologist who recently left his full-time clinical role at to devote himself to the emerging intersection of cancer care and psychedelics. Dr Konner shares how, after more than two decades treating people, he hit a wall. The accumulated grief, constant exposure to death, and intensity of oncology left him deeply , though he didn’t have that language for it at the time. A chance moment in a yoga class, overhearing someone say “ retreat” just before he was scheduled for hernia surgery, became the turning point....
info_outlinePsychedelics Today
Clinical psychologist Dr. Genesee Herzberg joins Kyle to reflect on two decades in trauma work and 15 years inside the psychedelic ecosystem—from early MAPS conferences to running Sage Integrative Health. She traces how personal psychedelic experiences set her on a path of service, research at CIIS on MDMA-assisted therapy, and hands-on roles with MAPS: Zendo Project harm reduction, adherence rating, and ultimately serving as an MDMA therapist in clinical trials. Today she leads Sage, an integrative clinic (psychotherapy, psychiatry, bodywork, acupuncture, and functional nutrition) focused...
info_outlinePsychedelics Today
Clinical psychologist joins to share insights from her decade of work with and her evolving focus on community-based integration. As the former Clinical Lead for , Dr. Watts witnessed how psychedelic experiences can foster profound feelings of — to self, others, and nature — yet also how that connection can fade without ongoing support. In this conversation, she reflects on what years of research have taught her about connectedness as both a healing mechanism and a human need. She explores how can transform fleeting psychedelic breakthroughs into lasting change, and why community is...
info_outlinePsychedelics Today
Artist, builder, and podcast host Jennifer Espenscheid joins Joe Moore for a rich conversation on creativity, process, and the spiritual dimensions of making art. Drawing from her South Dakota roots and large-scale works like Luciferia, Jennifer reflects on the blend of grit, intuition, and trust that guides her artistic life. She discusses how psychedelics have served as a tool for clarity and healing rather than direct creation of art, helping her dissolve patterns and reconnect to innate creativity. They explore how events like Burning Man catalyze inspiration, why intention and...
info_outlinePsychedelics Today
Brad Adams — LAMPS (Los Angeles Psychedelic Society) joins Kyle to trace his path from PhD researcher to community builder. Brad shares how early work in AIDS, Alzheimer’s, gerontology, and cancer research primed him to notice Harbor-UCLA’s psilocybin pilot for stage-4 cancer patients with death anxiety—where the strongest mystical experiences correlated with profound death acceptance. Teaming with Dennis McKenna, he ran an ayahuasca pilot in Peru and presented findings at Psychedelic Science 2017. From there, Brad founded LAMPS: first as research meetups at UCLA, then as a thriving...
info_outlineIn this episode, Joe interviews Joost Breeksema from the Netherlands to talk about the Interdisciplinary Conference on Psychedelic Research. In the show they cover topics on ICPR 2020, and the importance of accessibility.
3 Key Points:
- The Interdisciplinary Conference on Psychedelic Research takes place April 24-26, 2020 in the Netherlands.
- It's important to acknowledge the indigenous, ethical, and political dimensions to psychedelic use at conferences.
- Although this conference will be catered toward mainstream science and research, personal experiences and stories are important too.
Support the show
- Patreon
- Leave us a review on iTunes
- Share us with your friends – favorite podcast, etc
- Join our Facebook group - Psychedelics Today group – Find the others and create community.
Navigating Psychedelics
Show Notes
About Joost
- Joost is a part of the OPEN Foundation
- ICPR is a huge conference
- Nobody before was doing research on psychedelics in the Netherlands
- William James work sparked Joost’s interest in psychedelics
ICPR
- Starting with the OPEN Foundation, the conference has been very scientific
- It is interdisciplinary, but also taken very seriously
- This field is so broad, you could really never get bored
- Wade Davis, Alicia Danforth, Matt Johnson and more will be speaking at the conference
- There will be over 80 speakers
- Joost expects it to be a pretty international conference, half local, and half from abroad
- Psychiatrists are usually short on time, and they like things compressed more
- It's really easy and cheap to grow psilocybin as mushrooms or truffles
- Even in Mexico, they need to use GMP Psilocybin
Accessibility
- “If this is going to be the treatment, how are we going to help people afford it?” - Joe
- There is some tricky stuff happening, companies trying to patent different parts of psilocybin to use it for therapeutic use
- Ketamine has been off patent for years, but you can develop a new route of administration, patent that, and make a ton of money
- Spravato is making it to the UK
Conference Themes
- Joost is both excited and scared that they are bringing indigenous practitioners to the conference
- It's important to acknowledge the indigenous, ethical, and political dimensions to psychedelic use
- Talking about concepts and approaches to healing is going to be an important aspect
- The goal would be to do research with the indigenous communities to be able to address the needs of psychedelic use
- There are also a few neuroimaging people coming
- For mainstream scientists, the conference has to be as close to a scientific conference as possible, they may be turned off to the cultural aspects of psychedelics
- It's the conservative nature of psychedelia
- Joost also says that although the scientific research is important, it is really cool to hear the personal experiences
- Joe brings up a previous episode of a therapist and patient from the MDMA trials
- Stories are much more convincing than just data
- People’s experience with psychedelics may be completely different from each other
- It's important to share the bad stories with the good stories
- If we don't share the stories and data and research, then we can never learn
- Joe hopes that there will be a growth of citizen science in the near future
Links
About Joost

Joost Breeksema is a part of the OPEN Foundation, which from it came the Interdisciplinary Conference on Psychedelic Research. His current research focuses on the experiences of patients that are undergoing therapy assisted by psychedelic substances. His aim is to better understand psychological mechanisms of action/change, to tease out salient themes, and finally to learn about what works and what does not work in psychedelic-assisted psychotherapy.
Use code PSYTODAY at Onnit for a discount on all products except fitness equipment
Get a 30 day free audible trial at audibletrial.com/psychedelicstoday 


